The CAR-NK cell product studied in this trial ... These therapeutic CAR-NK cells are made from induced pluripotent stem cells derived from healthy donor fibroblast cell lines with centralized ...

However, a greater understanding of NK biology, coupled with the emergence of new technologies are leading to a resurgence of NK cell-based ... of induced pluripotent stem cells (iPSC) that ...

There’s use for pluripotent stem cells in disease diagnosis and treatment. Ultimately, Jing says, the hope is to both expand the giant panda population and make it healthier. The team’s ...

The ability to acquire high-quality NK cells in sufficient numbers represents a significant bottleneck in terms of NK cell application in adoptive immunotherapy. Induced pluripotent stem cells ...

FT536 (Fate Therapeutics) is an allogeneic, multiplexed-engineered induced pluripotent stem cell-derived natural killer (NK) cell therapy. Source: Adobe Stock. The agent is edited to include a ...

in-vitro from pluripotent stem cells—cells that are able to self-renew by dividing and developing into the three primary groups of cells that make up a human body. Now, researchers from Boston ...

Patient-derived induced pluripotent stem cell (iPSC) organoids have emerged as an innovative tool for disease modeling and drug evaluation. Growing evidence highlights the advantages of organoids ...